RDHL
Redhill BiopharmaยทNASDAQ
--
--(--)
--
--(--)
6.99 / 10
Outperform
Fund-flow metrics are mixed: the overall score of 6.99/10 indicates robust capital movement, yet trends at block, small, large, and extra-large scales are negative. Medium-scale flows show a positive trend, but the dominance of negative flows at other levels suggests limited conviction among investors, contributing to an overall cautious view.
Fund Flow Rating
What is the analyst consensus for RDHL?
- RDHL holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.99/10 (Outperform).
